Literature DB >> 8783373

Immunoregulatory properties of growth hormone and prolactin.

D A Weigent1.   

Abstract

Reciprocal communication between the neuroendocrine and immune systems is critical to the establishment of host homeostatic and defence mechanisms. The production and utilisation of common ligands and their receptors by cells of the immune and neuroendocrine systems constitutes a biochemical information circuit between and within the immune and neuroendocrine systems. Although the structures of the various signalling components appear to be similar in both systems, the regulation of their synthesis may be different. Growth hormone and prolactin have similar and marked influences on the function/activity of each of the major immune cell types, both in vitro and in vivo. The underlying molecular mechanisms are just beginning to be unravelled, and it is anticipated that further work in this rapidly developing field will establish abnormal pituitary and/or lymphocyte growth hormone and prolactin synthesis and function as a contributory factor to a number of pathologic situations, including leukaemia and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783373     DOI: 10.1016/0163-7258(96)00001-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  10 in total

Review 1.  Protein hormones and immunity.

Authors:  Keith W Kelley; Douglas A Weigent; Ron Kooijman
Journal:  Brain Behav Immun       Date:  2007-01-02       Impact factor: 7.217

Review 2.  Neuroendocrine control of photoperiodic changes in immune function.

Authors:  Zachary M Weil; Jeremy C Borniger; Yasmine M Cisse; Bachir A Abi Salloum; Randy J Nelson
Journal:  Front Neuroendocrinol       Date:  2014-10-18       Impact factor: 8.606

3.  A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation.

Authors:  Chunxia Lu; P Anil Kumar; Yong Fan; Mark A Sperling; Ram K Menon
Journal:  Endocrinology       Date:  2010-02-25       Impact factor: 4.736

Review 4.  Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models.

Authors:  Subhrajit Saha; Arlene Tieng; K Peter Pepeljugoski; Gisele Zandamn-Goddard; Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 5.  Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival.

Authors:  Nancie J Maciver; Sarah R Jacobs; Heather L Wieman; Jessica A Wofford; Jonathan L Coloff; Jeffrey C Rathmell
Journal:  J Leukoc Biol       Date:  2008-06-24       Impact factor: 4.962

6.  Concomitant Primary CNS Lymphoma and FSH-Pituitary Adenoma Arising Within the Sella. Entirely Coincidental?

Authors:  Vin Shen Ban; Bedansh Roy Chaudhary; Kieren Allinson; Thomas Santarius; Ramez Wadie Kirollos
Journal:  Neurosurgery       Date:  2017-01-01       Impact factor: 4.654

7.  Insulin-Like Growth Factor-I as an Effector Element of the Cytokine IL-4 in the Development of a Leishmania major Infection.

Authors:  Luiza C Reis; Eduardo Milton Ramos-Sanchez; Fabricio Petitto-Assis; Audun H Nerland; Maria Hernandez-Valladares; Frode Selheim; Lucile Maria Floeter-Winter; Hiro Goto
Journal:  Mediators Inflamm       Date:  2018-07-29       Impact factor: 4.711

8.  Influence of exercise and emotional stresses on secretion of prolactin and growth hormone in Thoroughbred horses.

Authors:  Tomoki Kitaura; Fumio Sato; Testuro Hada; Mutsuki Ishimaru; Rumi Kodama; Yasuo Nambo; Gen Watanabe; Kazuyoshi Taya
Journal:  J Equine Sci       Date:  2021-06-18

9.  Growth hormone and insulin-like growth factor 1 affect the severity of Graves' disease.

Authors:  Alfredo Di Cerbo; Federica Pezzuto; Alessandro Di Cerbo
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-06-07

10.  Inflammation and LPS-Binding Protein Enable the Stimulatory Effect of Endotoxin on Prolactin Secretion in the Ovine Anterior Pituitary: Ex Vivo Study.

Authors:  Dorota Tomaszewska-Zaremba; Karolina Haziak; Monika Tomczyk; Andrzej P Herman
Journal:  Mediators Inflamm       Date:  2018-08-14       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.